| PERIOD ENDING | 28-Mar-09 | 29-Mar-08 | 31-Mar-07 | | Total Revenue | 597,879 | 516,440 | 449,607 | | Cost of Revenue | 289,709 | 258,715 | 222,307 | | | Gross Profit | 308,170 | 257,725 | 227,300 | | | Operating Expenses | | Research Development | 23,859 | 24,322 | 23,884 | | Selling General and Administrative | 198,744 | 163,116 | 137,298 | | Non Recurring |
-
|
-
| 3,373 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 85,567 | 70,287 | 62,745 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (501) | 7,392 | 10,847 | | Earnings Before Interest And Taxes | 85,066 | 77,679 | 73,592 | | Interest Expense | 64 | 377 | 1,256 | | Income Before Tax | 85,002 | 77,302 | 72,336 | | Income Tax Expense | 25,698 | 25,322 | 23,227 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 59,304 | 51,980 | 49,109 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 59,304 | 51,980 | 49,109 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $59,304 | $51,980 | $49,109 |
|
1.48% Nasdaq 
Income Statement
